Correlation between the amplitude of glucose excursion and plasma 8-iso prostaglandin F2α level in subjects with different types of glucose regulation

National Medical Journal of China

Volumn 89, Issue 10, 2009, Pages 651-654

  Zheng, Fen Ping ^a   Wang, Zhou ^a   Li, Hong ^a   Jia, Cheng Fang ^a   Zhang, Nan ^a   Yuan, Hong Di ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

8 iso prostaglandin F2 ; Diabetes mellitus, type 2; Glucose excurtion; Oxidative stress

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; GLUCOSE; HEMOGLOBIN A1C;

ANALYTICAL PARAMETERS; AREA UNDER THE CURVE; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; MEAN AMPLITUDE OF GLYCEMIC EXCURSION; MEAN BLOOD GLUCOSE; MEAN POSTPRANDIAL GLUCOSE EXCURSION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PROSTAGLANDIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AREA UNDER CURVE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DINOPROST; FEMALE; GLUCOSE METABOLISM DISORDERS; HUMANS; MIDDLE AGED; OXIDATIVE STRESS; YOUNG ADULT;

EID: 77954935272     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.10.002     Document Type: Article

References (11)

1. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA, 2006, 295:1681-1687.
2. Gopaul NK, Anggard EE, Mallet AI, et al. Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett, 1995, 368:225-229.
3. Murai Y, Hishinuma T, Suzuki N, et al. Determination of urinary 8-epi-prostaglandin F (2alpha) using liquid chromatography-tandem mass spectrometry: increased excretion in diabetics. Prostaglandins Other Lipid Media, 2000, 62:173-181. (Pubitemid 30628458)
4. McDonnell CM, Donath SM, Vidmar SI, et al. A novel approach to continuous glucose analysis utilizing glyecmic variation. Diabetes Technol Ther, 2005, 7:253-263.
5. Mezzetti A, Cipollone F, Cuccurullo F, et al. Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm. Cardiovasc Res, 2000, 47:475-488. (Pubitemid 30646070)
6. Morrow JD. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol, 2005, 25:279-286.
7. Davi G, Ciaballoni G, Consoli A, et al. In vivo formation of 8-iso prostaglandin F2α and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation, 1999, 99:224-229.
8. Davi G, Chiarelli F, Santilli F, et al. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. Circulation, 2003, 107:3199-3203. (Pubitemid 36793091)
9. Sampson MJ, Gopaul N, Davies IR, et al. Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes. Diabetes Care, 2002, 25:537-541. (Pubitemid 41103349)
10. Quagliaro L, Piconi L, Assaloni R. Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis, 2005, 110:259-267.